SB Krantz

4.1k citations
43 papers · 3.4k indexed · 1 hit paper · h-index 24

Impact in

  • Hematology top 0.2%
    • Erythropoietin and Anemia Treatment
    • Iron Metabolism and Disorders
    • Acute Myeloid Leukemia Research
    • Blood groups and transfusion
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Hemoglobinopathies and Related Disorders
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Erythropoietin and Anemia Treatment 17
    • Blood groups and transfusion 14
    • Hematopoietic Stem Cell Transplantation 8
    • Hemoglobinopathies and Related Disorders 12
    • Blood disorders and treatments 5

SB Krantz

43 papers receiving 3.2k citations

Hit Papers

Erythropoietin 1991 · 759 citations
7591991202620022014250500750

Peers

SB Krantz
Comparison fields: 5 of 104
  • Hematology 2.2k
  • Genetics 1.0k
  • Physiology 1.0k
  • Biochemistry 177
  • Immunology 516
Replace DG Nathan with:
DG Nathan United States
Sanford B. Krantz United States
Harvey R. Gralnick United States
Bruce M. Ewenstein United States
K Sawada Japan
Paul Friese United States
H Rochant France
A. Salama Germany
F L Johnson United States
Francisco España Spain
SB Krantz relative to DG Nathan United States DG Nathan's profile →
Citations per field
00.5×
DG Nathan · 1×
Citations per year

Countries citing papers authored by SB Krantz

Since Specialization
Citations

This map shows the geographic impact of SB Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SB Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SB Krantz more than expected).

Fields of papers citing papers by SB Krantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SB Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SB Krantz. The network helps show where SB Krantz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside SB Krantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SB Krantz Line = papers co-authored together SB Krantz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199425
2 19941
3 1992120
4 19925
5 1992479
6 199298
7 19913
8 1991119
9 19917
10 19919
11
Growth of highly purified human CFU-E in serum-free medium.
19903
12 198974
13 198893
14
Specific binding of erythropoietin to human erythroid colony-forming cells.
19874
15 198546
16 198430
17 198486
18 19836
19 19821
20 198027

About SB Krantz

SB Krantz is a scholar working on Hematology, Genetics, Physiology, Immunology and Pediatrics, Perinatology and Child Health, having authored 43 papers that have together received 3.4k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (31 papers), Erythropoietin and Anemia Treatment (17 papers), Blood groups and transfusion (14 papers), Hemoglobinopathies and Related Disorders (12 papers), Hematopoietic Stem Cell Transplantation (8 papers), Blood disorders and treatments (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (1.0k citations), Physiology (1.0k citations), Biochemistry (177 citations) and Immunology (516 citations). SB Krantz has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Robert T. Means, EN Dessypris, MC Bondurant, Chunhua Dai, Amittha Wickrema, R S Stein, JC Winkelmann, K Sawada, ST Sawyer and Clark Da. Their work appears in journals such as Blood and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026